About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

UNKNOWNNA

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

NCT03302403•Kang YU

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

B Cell LymphomaB Cell LeukemiaMyeloma+3 more

Interventions

CAR-CD19 T cell

CAR-BCMA T cell

+4 more

Locations

1

China

Locations (1)

First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Key Dates

Start Date

December 29, 2017

Primary Completion Date

December 12, 2020

Completion Date

December 12, 2023

Last Updated

October 8, 2020

Related Studies

RECRUITINGPhase 2

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT06179888

Multiple Myeloma

RECRUITINGPhase 3

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

NCT06152575

Multiple Myeloma

RECRUITINGPhase 1/2

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT04973605

Relapsed/Refractory Multiple Myeloma

RECRUITINGPhase 1/2

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

B-cell MalignancyMarginal Zone Lymphoma+7 more

RECRUITINGPhase 4

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

NCT05201781

Multiple Myeloma

RECRUITINGPhase 1

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

NCT06026319

Non-hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma+8 more

View all related studies

Sponsors

Lead Sponsor

Kang YU

Collaborators

CARsgen Therapeutics Co., Ltd.

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 8, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions